In 2023, the sales of blood and blood-forming organs medicine in Japan were recorded at 5.72 billion US dollars. A year-on-year increase of approximately 0.87% is forecasted for each subsequent year through 2028, reflecting a steady growth trend. The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is calculated to be around 0.87%, indicating consistent market expansion.
Future trends to watch for include potential impacts of healthcare policy changes, the integration of advanced technologies in medicine, and shifts in demographic dynamics such as the aging population, which could further influence market demand and growth in this sector.
